Minimally Invasive Surgery for Rectal Adenocarcinoma Shows Promising Outcomes Compared to Laparotomy, a National...

Area of Science:

• Oncology
• Surgical Oncology
• Gastrointestinal Surgery

Background:

• Rectal adenocarcinoma surgical management is debated.
• Existing studies on minimally invasive surgery (MIS) for rectal cancer may lack statistical power.
• Laparotomy versus MIS for rectal cancer survival requires further investigation.

Purpose of the Study:

• To compare survival outcomes between minimally invasive surgery (MIS) and laparotomy for rectal adenocarcinoma.
• To evaluate the impact of surgical approach on survival across different stages of rectal cancer.
• To assess oncologic outcomes, including margin status and lymph node yield, in MIS versus open surgery for rectal cancer.

Main Methods:

• Analysis of the National Cancer Database (NCDB) from 2010 to 2014.
• Inclusion of patients with invasive adenocarcinoma of the rectum undergoing surgical resection.
• Stratification by NCDB Analytic Stage and multivariate Cox regression for survival analysis.

Main Results:

• Minimally invasive surgery (MIS) was associated with improved survival for rectal adenocarcinoma patients (adjusted HR=0.82, P<.001).
• The survival benefit of MIS was observed across all stages (I-IV) of rectal cancer.
• MIS demonstrated higher rates of negative circumferential margins, improved proximal/distal margins, and greater lymph node yield compared to laparotomy.

Conclusions:

• Minimally invasive resection for rectal adenocarcinoma provides a significant survival advantage over open surgery.
• MIS is associated with superior oncologic outcomes in rectal cancer treatment.
• These findings support the broader adoption of MIS for rectal adenocarcinoma management.